We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Growth of Zika virus in Brain Stem Cells Implies Involvement in Microcephaly

By LabMedica International staff writers
Posted on 15 Mar 2016
Experiments conducted in cultured human embryonic cortical neural progenitor cells (hNPCs) have demonstrated that these cells are readily infected by the Zika virus (ZIKV), which induces the cells to produce new Zika virus particles while disrupting normal cell metabolism in a fashion that eventually kills the cells.

Investigators at Johns Hopkins University (Baltimore, MD, USA) and colleagues at Florida State University (Tallahassee, USA) and Emory University (Atlanta, GA, USA) worked with hNPCs that had been derived from human induced pluripotent stem cells.

They reported in the March 4, 2016, online edition of the journal Cell Stem Cell that a strain of the ZIKV, MR766, serially passaged in monkey and mosquito cells efficiently infected hNPCs (more than 90% of cells were infected within three days). More...
Infected hNPCs further released infectious ZIKV particles. ZIKV infection increased cell death and disrupted cell-cycle progression, resulting in attenuated hNPC growth.

Global gene expression analysis of infected hNPCs revealed transcriptional dysregulation, notably of cell-cycle-related pathways.

The results of this study point to hNPCs as being directly targeted by ZIKV. Furthermore, they describe an experimental model system to investigate the impact and mechanism of ZIKV on human brain development and provide a platform to screen therapeutic compounds.

“Studies of fetuses and babies with the telltale small brains and heads of microcephaly in Zika-affected areas have found abnormalities in the cortex, and Zika virus has been found in the fetal tissue,” said senior author Dr. Guo-li Ming, professor of neurology, neuroscience, psychiatry, and behavioral science at Johns Hopkins University. “While this study does not definitely prove that Zika virus causes microcephaly, it is very telling that the cells that form the cortex are potentially susceptible to the virus, and their growth could be disrupted by the virus.”

Related Links:

Johns Hopkins University
Florida State University
Emory University



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.